Our proband has been previously mentioned in a report of Lynch Syndrome variants [18] but we are not aware of other descriptions of the co-existence of breast tumour, sarcoma, colorectal cancer and prostate cancer in a single proband with an hMLH1 mutation. Here, MLH1 is linked to breast neoplasm.